AVI-6003 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Marburg Hemorrhagic Fever
Conditions
Marburg Hemorrhagic Fever
Trial Timeline
May 1, 2011 → Dec 1, 2011
NCT ID
NCT01353040About AVI-6003 + Placebo
AVI-6003 + Placebo is a phase 1 stage product being developed by United Therapeutics for Marburg Hemorrhagic Fever. The current trial status is completed. This product is registered under clinical trial identifier NCT01353040. Target conditions include Marburg Hemorrhagic Fever.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01353040 | Phase 1 | Completed |
Competing Products
2 competing products in Marburg Hemorrhagic Fever
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AVI-7288 | United Therapeutics | Phase 1 | 30 |
| galidesivir + placebo | BioCryst Pharmaceuticals | Phase 1 | 28 |